Ming Hsien Lin

Dr. Ming Hsien Lin

Director, Department of Nuclear Medicine, Camillian Saint Mary's Hospital Luodong
orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2015 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
CCChih-Chao Chang
Chih-Chao Chang
CCChih-Hsien Chang
Chih-Hsien Chang
CSChih-Chieh Shen
Chih-Chieh Shen
CCChuan-Lin Chen
Chuan-Lin Chen
RLRen-Shyan Liu
Ren-Shyan Liu
HWHsin-Ell Wang
Hsin-Ell Wang

1 August 2016 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
CCChih-Chao Chang
Chih-Chao Chang
CCChih-Hsien Chang
Chih-Hsien Chang
YLYi-Hsuan Lo
Yi-Hsuan Lo
Ming Hsien LinMing Hsien Lin
Ming Hsien Lin
CSChih-Chieh Shen
Chih-Chieh Shen
CCChuan-Lin Chen
Chuan-Lin Chen

1 January 2016 in European Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
CCChih-Hsien Chang
Chih-Hsien Chang
CSChih-Chieh Shen
Chih-Chieh Shen
CCChuan-Lin Chen
Chuan-Lin Chen
RLRen-Shyan Liu
Ren-Shyan Liu
Ming Hsien LinMing Hsien Lin
Ming Hsien Lin
HWHsin-Ell Wang
Hsin-Ell Wang

1 July 2012 in Archives of Gerontology and Geriatrics
Verified
Journal Article
Closed access
Ming Hsien LinMing Hsien Lin
Ming Hsien Lin
CLChien-Liang Liu
Chien-Liang Liu
LPLi-Ning Peng
Li-Ning Peng
YCYi-Tsun Chen
Yi-Tsun Chen
LCLiang-Kung Chen
Liang-Kung Chen

6 May 2011 in Journal of Clinical Gerontology and Geriatrics
Verified
Journal Article
Open access
PDF file
LPLi-Ning Peng
Li-Ning Peng
CLChien-Liang Liu
Chien-Liang Liu
Ming Hsien LinMing Hsien Lin
Ming Hsien Lin
SHShinn-Jang Hwang
Shinn-Jang Hwang
LCLiang-Kung Chen
Liang-Kung Chen
Background: Hypertension is common and often left undiagnosed in the elderly. The main purpose of this study was to evaluate the clinical characteristics of nondiabetic hypertensive older adults. Methods: Community-living older adults in Taipei City participating in annual health examinations were invited for study. Subjects with diabetes mellitus, whether treated or newly diagnosed, were excluded for further analysis. All participants were classified into three groups: normotension, untreated hypertension (UH), and treated hypertension (TH). Results: In total, 3244 subjects (mean age: 73.4 ± 5.4 years, 56.2% males) were enrolled. The prevalence of hypertension, chronic kidney disease (CKD), and left ventricular hypertrophy (LVH) was 52.9% (36.1% TH and 16.8% UH), 20.9%, and 6.2%, respectively. Compared with the normotension group, UH subjects were older (73.8 ± 5.5 years vs. 72.9 ± 5.6 years, p = 0.003); having higher body mass index (24.2 ± 3.4 kg/m2vs. 23.6 ± 3.4 kg/m2, p = 0.001), fasting glucose (101.7 ± 9.1 mg/dL vs. 100.5 ± 9.0 mg/dL, p = 0.007), total cholesterol (TC) (205.0 ± 37.8 mg/dL vs. 196.5 ± 36.4 mg/dL, p < 0.001), triglyceride (TG) (134.5 ± 84.9 mg/dL vs. 119.4 ± 77.0 mg/dL, p < 0.001); and higher prevalence of overt proteinuria (19.3% vs. 13.5%, p = 0.001), CKD (21.1% vs. 16.6%, p = 0.025), and LVH (8.1% vs. 3.8%, p < 0.001). However, the prevalence of overt proteinuria (19.3% vs. 21.1%, p = 0.378) and LVH (8.1% vs. 8.5%, p = 0.79) between UH and TH groups was similar. Adjusted for age, TC, TG, fasting plasma glucose, and the incidence of LVH, both UH [odds ratio (OR) = 1.30, 95% confidence interval (CI) = 1.01–1.66, p = 0.040] and TH (OR = 1.69, 95% CI = 1.39–2.05, p < 0.001) were significant risk factor for CKD. In addition, independent risk factors for CKD included age (OR = 1.07, 95% CI = 1.05–1.09, p < 0.001), body mass index (OR = 1.07, 95% CI = 1.04–1.10, p < 0.001), TC (OR = 1.003, 95% CI = 1.001–1.005, p = 0.021), TG (OR = 1.002, 95% CI = 1.001–1.003, p < 0.001), and hypertension (TH or UH) (OR = 1.44, 95% CI = 1.20–1.72, p < 0.001). Conclusion: In conclusion, risk of CKD existing along with blood pressure rises among nondiabetic older hypertensive adults, and hypertension (TH or UH) carries a significant risk of CKD after adjustment of other cardiovascular risk factors. Renal protection should be highlighted in the antihypertensive treatment strategy in older hypertensive patients.

1 January 2010 in Archives of Gerontology and Geriatrics
Verified
Journal Article
Closed access
SJShiow-Jen Juang
Shiow-Jen Juang
LPLi-Ning Peng
Li-Ning Peng
Ming Hsien LinMing Hsien Lin
Ming Hsien Lin
HLHsiu-Yun Lai
Hsiu-Yun Lai
SHShinn-Jang Hwang
Shinn-Jang Hwang
SCShu-Ti Chiou
Shu-Ti Chiou